.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Merck
Julphar
Moodys
Healthtrust
Baxter
QuintilesIMS
Chubb
Covington
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,173,107

« Back to Dashboard

Which drugs does patent 8,173,107 protect, and when does it expire?


Patent 8,173,107 protects ADASUVE and is included in one NDA.

This patent has one hundred and ninety-six patent family members in nineteen countries.

Summary for Patent: 8,173,107

Title:Delivery of antipsychotics through an inhalation route
Abstract: The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a method aspect of the present invention, an antipsychotic is delivered to a patient through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises an antipsychotic, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles with less than 5% antipsychotic drug degradation products. In a kit aspect of the present invention, a kit for delivering an antipsychotic through an inhalation route is provided which comprises: a) a thin coating of an antipsychotic composition and b) a device for dispensing said thin coating as a condensation aerosol.
Inventor(s): Rabinowitz; Joshua D. (Princeton, NJ), Zaffaroni; Alejandro C. (Atherton, CA)
Assignee: Alexza Pharmaceuticals, Inc. (Mountain View, CA)
Application Number:12/413,339
Patent Claim Types:
see list of patent claims
Delivery; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Galen Uk ADASUVEloxapinePOWDER;INHALATION022549-001Dec 21, 2012RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,173,107

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,805,854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route► Subscribe
6,803,031 Delivery of erectile dysfunction drugs through an inhalation route► Subscribe
7,087,218Delivery of diazepam through an inhalation route► Subscribe
7,458,374Method and apparatus for vaporizing a compound► Subscribe
6,740,307 Delivery of .beta.-blockers through an inhalation route► Subscribe
8,074,644Method of forming an aerosol for inhalation delivery► Subscribe
6,814,955 Delivery of physiologically active compounds through an inhalation route► Subscribe
7,063,831Delivery of erectile dysfunction drugs through an inhalation route► Subscribe
7,018,621Delivery of rizatriptan or zolmitriptan through an inhalation route► Subscribe
7,022,312Delivery of antiemetics through an inhalation route► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,173,107

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria365548► Subscribe
Austria401063► Subscribe
Austria401064► Subscribe
Austria404173► Subscribe
Austria404184► Subscribe
Austria406878► Subscribe
Austria415155► Subscribe
Austria418330► Subscribe
Austria418971► Subscribe
Austria425746► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Express Scripts
Chubb
Novartis
McKesson
Boehringer Ingelheim
Cerilliant
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot